Home Authors Posts by Kirk Falconer

Kirk Falconer

Pythian, a provider of data management consulting and services, has secured $6 million in new funding. The investors included the Business Development Bank of Canada (BDC) and Royal Bank of Canada (RBC). Proceeds of the investment will be used to expand the market reach of the company's leading product offering, Adminiscope, a data security solution that is focused on helping global retailers eliminate data security breaches. Founded in 1997, Pythian has it headquarters in Ottawa.
Aurinia Pharmaceuticals Inc (TSX-V: AUP) has completed a US$52 million private placement. The deal was led by venBio, New Enterprise Associates, Redmile Group, RA Capital Management, Great Point Partners and Apple Tree Partners, with the participation of existing investors Lumira Capital, ILJIN Life Science and Difference Capital. Lumira, Difference Capital and ILJIN in 2013 helped finance Aurinia's merger with Isotechnika Pharma Inc. The Edmonton-based company intends to use the new funds for the clinical and non-clinical development of its lead drug candidate, a therapy for treating lupus nephritis. Aurinia's current leadership team includes former senior managers of Aspreva Pharmaceuticals Corp, which was acquired in 2008.
Boris Wertz’s instiutional seed fund is just over a year old, but has risen to become one of the top 10 seed funds in North America
Axine Water Technologies Inc said Wednesday that it has raised $5.6 million in a Series A financing round. The investors included U.S. venture capital firm The Roda Group, and Canadian firms Chrysalix Energy Venture Capital and BDC Venture Capital, which are existing investors. Based in Vancouver, British Columbia, Axine Water Technologies is a developer of chemical-free solutions that treat pollutants in industrial wastewater. Update: Funding proceeds will be used to ensure Axine's continued progress towards commercialization of its wastewater treatment technology platform. The company has been venture-backed since 2012.
Response Biomedical Corp (TSX: RBM)(OTCBB: RPBIF) has received a US$2.5 million term loan from Silicon Valley Bank. Headquartered in Vancouver, British Columbia, Response Biomedical develops, manufactures and markets rapid on-site diagnostic tests for use with its RAMP platform for clinical, biodefense and environmental applications. Update: The company plans to use funds from the loan to support working capital needs for growing its markets both in the United States and internationally, and for general corporate purposes.
Acquisio Inc has received expansion funding from Canadian technology-focused venture capital firm Emerillon Capital. The financial terms of the deal were not published. Acquisio, ranked 7th in the 2013 Deloitte Fast 50™, will use investment proceeds to accelerate growth through strategic acquisitions. Founded in 2003, the Brossard, Québec-based company provides digital marketers with a performance media platform that enables them to optimize the results of their search, social, mobile, and display marketing programs. Venture-backed since 2011, Acquisio's other investors include the Fonds de solidarité des travailleurs du Québec FTQ and Tandem Expansion Fund. Emerillon Capital was established in 2013 through a partnership between Groupe Crédit Mutuel – CIC and Mouvement Desjardins.
Boris Wertz launched Version One Ventures with the aspiration of making it “one of the top 10 seed funds in North America.” Less than a year later, he appears to have realized that ambition. U.S. data platform Mattermark last month ranked Vancouver-based Version One as No. 8 on a list of 115 leading VC investors. PeHUB Canada Editor Kirk Falconer sat down with Wertz to find out his secret to success.
ResponseTek Networks Corp, a provider of enterprise customer experience management (CEM) software solutions, has secured a $6 million round of financing from Beedie Capital Partners and GrowthWorks. Proceeds of the investment will be used to support the company's continued growth and expansion into the Middle East and Asia. Based in Vancouver, ResponseTek has implemented CEM programs using its ReponseTek Listening Platform™ in over 30 countries throughout North America, Europe and Asia, according to the company. ResponseTex has been venture-backed since 2001. Its other investors include BDC Venture Capital and MMV Capital Partners.
Triphase Accelerator Corp, a cancer-focused biotechnology accelerator, has been formed by an investment partnership of Fight Against Cancer Innovation Trust (FACIT) and affiliates of commercialization and innovation hubs MaRS Innovation and MaRS Discovery District. With operations in Toronto and San Diego, Calif., Triphase aims to support differentiated products through proof of concept (Phase II) faster and more efficiently. Originally spun out of the Ontario Institute for Cancer Research in 2010, Triphase has entered into a strategic relationship with Celgene Corp, a manufacturer of drug therapies for cancer and inflammatory disorders with headquarters in Summit, New Jersey.
Shopify Inc said Thursday that it has raised $100 million in Series C funding. OMERS Ventures and Insight Venture Partners led the round with participation from Bessemer Venture Partners, FirstMark Capital, Georgian Partners and Felicis Ventures. According to the company, the capital infusion will be used to expand its recently launched offline retail offering. Based in Ottawa, Ontario, Shopify is an e-commerce and retail platform. Update: The Series C round raised by the company brings its total venture capital investment since 2010 to over $120 million.
vcj
vcj

Copyright PEI Media

Not for publication, email or dissemination